Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Clinical trial NCT00049543 · COMPLETED

Trial details

NCT number: NCT00049543
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma of the Lung Adenosquamous Cell Lung Cancer Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Squamous Cell Lung Cancer Stage IB Non-small Cell Lung Cancer Stage IIA Non-small Cell Lung Cancer Stage IIB Non-small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer

Start date: 2002-09-01
Primary completion: 2011-04-01
Enrollment: 503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.